NCT00161070View on ClinicalTrials.gov

ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

4,500

Participants

Timeline

Start Date

July 31, 1997

Study Completion Date

December 31, 2006

Conditions
Brain IschemiaTransient Ischemic AttackArteriosclerosis
Interventions
DRUG

anticoagulation

DRUG

aspirin and dipyridamole

DRUG

aspirin alone

Trial Locations (1)

Unknown

UMC Utrecht, Utrecht

All Listed Sponsors
lead

UMC Utrecht

OTHER

NCT00161070 - ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial | Biotech Hunter | Biotech Hunter